CRH.TO - CRH Medical Corporation

Toronto - Toronto Delayed Price. Currency in CAD
Currency in CAD

Valuation Measures

Market Cap (intraday) 5
281.08M
Enterprise Value 3
394.61M
Trailing P/E
67.76
Forward P/E 1
35.73
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
2.30
Price/Book (mrq)
3.75
Enterprise Value/Revenue 3
3.23
Enterprise Value/EBITDA 6
7.38

Trading Information

Stock Price History

Beta (3Y Monthly) 1.36
52-Week Change 3-3.98%
S&P500 52-Week Change 318.10%
52 Week High 35.0400
52 Week Low 33.3700
50-Day Moving Average 34.0251
200-Day Moving Average 33.9149

Share Statistics

Avg Vol (3 month) 340.63k
Avg Vol (10 day) 349.57k
Shares Outstanding 571.52M
Float 58.01M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short (Oct 31, 2019) 42.26M
Short Ratio (Oct 31, 2019) 484.07
Short % of Float (Oct 31, 2019) 43.17%
Short % of Shares Outstanding (Oct 31, 2019) 43.14%
Shares Short (prior month Sep 30, 2019) 42.32M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Apr 29, 1998
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin 3.49%
Operating Margin (ttm)15.72%

Management Effectiveness

Return on Assets (ttm)5.87%
Return on Equity (ttm)8.23%

Income Statement

Revenue (ttm)122.04M
Revenue Per Share (ttm)1.68
Quarterly Revenue Growth (yoy)5.90%
Gross Profit (ttm)26.75M
EBITDA 53.49M
Net Income Avi to Common (ttm)4.26M
Diluted EPS (ttm)0.0580
Quarterly Earnings Growth (yoy)268.20%

Balance Sheet

Total Cash (mrq)5.22M
Total Cash Per Share (mrq)0.07
Total Debt (mrq)68.42M
Total Debt/Equity (mrq)57.85
Current Ratio (mrq)2.83
Book Value Per Share (mrq)1.05

Cash Flow Statement

Operating Cash Flow (ttm)43.81M
Levered Free Cash Flow (ttm)41.57M